Diisopropylethylamine → N-((2',5-dimethyl-3,4'-bipyridin-6-yl)methyl)-5-(pyrazin-2-yl)picolinamide
Reaction equation
[N:1]1[CH:6]=[CH:5][N:4]=[CH:3][C:2]=1[C:7]1[CH:8]=[CH:9][C:10]([C:13]([OH:15])=O)=[N:11][CH:12]=1.[CH3:16][C:17]1[CH:22]=[C:21]([C:23]2[CH:24]=[N:25][C:26]([CH2:30][NH2:31])=[C:27]([CH3:29])[CH:28]=2)[CH:20]=[CH:19][N:18]=1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.CCN(C(C)C)C(C)C>CN(C=O)C.CS(C)=O>[CH3:16][C:17]1[CH:22]=[C:21]([C:23]2[CH:24]=[N:25][C:26]([CH2:30][NH:31][C:13](=[O:15])[C:10]3[CH:9]=[CH:8][C:7]([C:2]4[CH:3]=[N:4][CH:5]=[CH:6][N:1]=4)=[CH:12][N:11]=3)=[C:27]([CH3:29])[CH:28]=2)[CH:20]=[CH:19][N:18]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To a mixture of 5-(pyrazin-2-yl)picolinic acid 41-4 (20 mg, 0.1 mmol), (2′,5-dimethyl-3,4′-bipyridin-6-yl)methanamine 81-5 (21 mg, 0.1 mmol) and O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluroniumhexafluorophosphate (HATU) (38 mg, 0.1 mmol) in DMF (1.0 mL) was added DIEA (0.053 mL, 0.3 mmol) at room temperature. The mixture was stirred at room temperature for 2 hours. The reaction mixture was diluted into DMSO and purified by HPLC to give N-42′,5-dimethyl-[3,4′-bipyridin]-6-yl)methyl)-5-(pyrazin-2-yl)picolinamide 81 as a white solid. MS m/z 397.2 (M+1). 1H NMR 400 MHz (DMSO-d6) δ 9.60 (t, 1H), 9.54 (d, 1H), 9.52 (d, 1H), 8.99 (d, 1H), 8.91 (m, 1H), 8.82-8.80 (m, 2H), 8.66 (d, 1H), 8.33 (d, 1H), 8.20 (d, 1H), 7.87 (s, 1H), 7.79 (b, 1H), 4.81 (d, 2H), 2.64 (s, 3H), 2.51 (s, 3H).
Workup
- custompurified by HPLC
Sources & evidence
- ORD record
- ord-49e154241c2a4b58aee4de46bf19fd84
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181235B2
Reaction notes
Loading…